Article Versions Notes

Shibata S, Sakurai K, Tachikawa K, Ko R, Hino S, Fukano T, Isahaya K, Haraguchi T, Yamauchi J, Tanabe K, et al. The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy. Neurology International. 2022; 14(4):981-990. https://doi.org/10.3390/neurolint14040077

Shibata, Soichiro, Kenzo Sakurai, Keiji Tachikawa, Riyoko Ko, Sakae Hino, Takayuki Fukano, Kenji Isahaya, Takafumi Haraguchi, Junji Yamauchi, Kenichiro Tanabe, and et al. 2022. "The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy" Neurology International 14, no. 4: 981-990. https://doi.org/10.3390/neurolint14040077

Shibata, S., Sakurai, K., Tachikawa, K., Ko, R., Hino, S., Fukano, T., Isahaya, K., Haraguchi, T., Yamauchi, J., Tanabe, K., Nagasaka, M., Hagiwara, Y., Shimizu, T., Akiyama, H., Kobayashi, Y., Hasegawa, Y., & Yamano, Y. (2022). The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy. Neurology International, 14(4), 981-990. https://doi.org/10.3390/neurolint14040077